Education
About Us
Working with TipRanks
Follow Us
Entera Bio Ltd (ENTX)
NASDAQ:ENTX
Total Valuation
Entera Bio has a market cap or net worth of $83.11M. The enterprise value is $70.32M.
Market Cap$83.11M
Enterprise Value$70.32M
Share Statistics
Entera Bio has 45,663,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,663,380
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Entera Bio’s return on equity (ROE) is -1.18 and return on invested capital (ROIC) is -112.22%.
Return on Equity (ROE)-1.18
Return on Assets (ROA)-1.02
Return on Invested Capital (ROIC)-112.22%
Return on Capital Employed (ROCE)-1.17
Revenue Per Employee10.06K
Profits Per Employee-530.06K
Employee Count18
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Entera Bio is ―. Entera Bio’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value9.88
Price to FCF―
Price to Operating Cash Flow-14.07
PEG Ratio―
Income Statement
In the last 12 months, Entera Bio had revenue of 181.00K and earned -9.54M in profits. Earnings per share was -0.25.
Revenue181.00K
Gross Profit9.00K
Operating Income-9.59M
Pretax Income-9.53M
Net Income-9.54M
EBITDA-9.54M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -6.66M and capital expenditures -40.00K, giving a free cash flow of -6.70M billion.
Operating Cash Flow-6.66M
Free Cash Flow-6.70M
Free Cash Flow per Share-0.15
Dividends & Yields
Entera Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-4.21%
50-Day Moving Average1.92
200-Day Moving Average2.03
Relative Strength Index (RSI)44.48
Average Volume (3m)69.39K
Important Dates
Entera Bio upcoming earnings date is Nov 6, 2025, After Close (Confirmed).
Last Earnings DateAug 8, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Entera Bio as a current ratio of 7.63, with Debt / Equity ratio of 1.18%
Current Ratio7.63
Quick Ratio7.63
Debt to Market Cap<0.01
Net Debt to EBITDA0.88
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Entera Bio has paid 14.00K in taxes.
Income Tax14.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Entera Bio EV to EBITDA ratio is -7.49, with an EV/FCF ratio of -10.47.
EV to Sales394.64
EV to EBITDA-7.49
EV to Free Cash Flow-10.47
EV to Operating Cash Flow-10.48
Balance Sheet
Entera Bio has $10.86M in cash and marketable securities with $203.00K in debt, giving a net cash position of $10.65M billion.
Cash & Marketable Securities$10.86M
Total Debt$203.00K
Net Cash$10.65M
Net Cash Per Share$0.23
Tangible Book Value Per Share$0.21
Margins
Gross margin is -4.22%, with operating margin of -5295.58%, and net profit margin of -5271.27%.
Gross Margin-4.22%
Operating Margin-5295.58%
Pretax Margin-5263.54%
Net Profit Margin-5271.27%
EBITDA Margin-5270.17%
EBIT Margin-5295.58%
Analyst Forecast
The average price target for Entera Bio is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside449.45% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast191.23%
EPS Growth Forecast2.17%